ADPT vs CPB · rev $142.4M vs P/E 12, rev $10.25B
Adaptive Biotechnologies Corp (ADPT) versus Campbell’s Co (CPB) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
ADPT currently screens at market cap $2.69B. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Not investment advice. Open the ADPT and CPB stock pages for the full models.
Not investment advice.